Nurse Center

 
 

Rituxan Nurse Center

The Rituxan.com Nurse Center provides helpful resources and information about Rituxan for RA. To access the Nurse Center features, including a Resource Library, Patient Discussion Guide and Infusion Guide, click on any of the icons below.

  • Resource Library icon Resource Library

    The Resource Library features brochures, slide decks and other resources focused on Rituxan and RA, and allows you to create customized resource packets that can be printed out or emailed to colleagues and patients.

  • Discussion Guide icon Discussion Guide

    The Patient Discussion Guide provides information designed to help you prepare your patients for Rituxan therapy. This feature also allows you to create a customized Discussion Guide tailored to your patients' specific needs.

  • Treatment Guide icon Treatment Guide

    The Rituxan Treatment Guide provides step-by-step instructions for the administration of Rituxan, and includes a supply list, adverse event information, information about managing severe reactions and a drip-rate table to help you calculate infusion concentrations.

Sign up for updates - Keep up to date on Rituxan Nurse Center material. Click here to sign-up.

Next Section: Important Safety Information

 

Indication

Rituxan® (rituximab) in combination with methotrexate is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.

Rituxan is not recommended for treatment of patients with severe active infections.

Important Safety Information

  • Rituxan has been associated with fatal infusion reactions, tumor lysis syndrome (TLS), severe mucocutaneous reactions, and progressive multifocal leukoencephalopathy (PML)
  • Hepatitis B reactivation, cardiac arrhythmias, and angina have also been observed
  • Patients should be closely observed for signs of infection if biologic agents and/or DMARDs other than methotrexate are used concomitantly
  • Common adverse reactions include infusion reactions and infections

Please see full prescribing information, including Boxed Warnings for additional safety information.